Updated Jul 16, 2026
Naos Yaron is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Naos Yaron is an executive associated with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutic proteins based on its proprietary ProCellEx platform. He has been involved in various capacities within the company, contributing to its strategic direction and operational management.
| Role | Insider |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-03 | PLX | Protalix BioTherapeutics, Inc. | A — Grant or award | 25.0K | — |
Naos Yaron is an executive associated with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutic proteins based on its proprietary ProCellEx platform. He has been involved in various capacities within the company, contributing to its strategic direction and operational management.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Naos Yaron profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.